MWA
INBX icon

Meridian Wealth Advisors’s Inhibrx INBX Stock Holding History

Meridian Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$805K Sell
8,500
-2,000
-19% -$200K 0.09% 113
2026
Q1 		$706K Hold
10,500
– – 0.09% 116
2025
Q4 		$830K Sell
10,500
-14,500
-58% -$988K 0.11% 101
2025
Q3 		$842K Hold
25,000
– – 0.12% 100
2025
Q2 		$357K Hold
25,000
– – 0.06% 139
2025
Q1 		$350K Hold
25,000
– – 0.06% 135
2024
Q4 		$385K Buy
+25,000
New +$381K 0.06% 131

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Meridian Wealth Advisors's INBX Position: Q2 2026 in Review

Meridian Wealth Advisors reduced its Inhibrx (INBX) stake by 19% in Q2 2026, selling an estimated $200K and leaving 8,500 shares worth $805K. The position accounts for 0.09% of the portfolio, ranked #113.

Meridian Wealth Advisors first reported a position in INBX in Q4 2024 and has held it in 7 quarters since. The position peaked at $842K in Q3 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Meridian Wealth Advisors held 8,500 shares of Inhibrx worth $805K as of Q2 2026.
  • Meridian Wealth Advisors sold 2,000 Inhibrx shares in Q2 2026, an estimated $200K.
  • Inhibrx made up 0.09% of Meridian Wealth Advisors's portfolio in Q2 2026, its #113 holding.
  • Meridian Wealth Advisors first reported a position in Inhibrx in Q4 2024 and has held it in 7 quarters since.
  • Meridian Wealth Advisors's Inhibrx position peaked at $842K in Q3 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.